187 related articles for article (PubMed ID: 25782675)
1. Phenotypic expansion of visceral myopathy associated with ACTG2 tandem base substitution.
Klar J; Raykova D; Gustafson E; Tóthová I; Ameur A; Wanders A; Dahl N
Eur J Hum Genet; 2015 Dec; 23(12):1679-83. PubMed ID: 25782675
[TBL] [Abstract][Full Text] [Related]
2. Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathy.
Lehtonen HJ; Sipponen T; Tojkander S; Karikoski R; Järvinen H; Laing NG; Lappalainen P; Aaltonen LA; Tuupanen S
Gastroenterology; 2012 Dec; 143(6):1482-1491.e3. PubMed ID: 22960657
[TBL] [Abstract][Full Text] [Related]
3. New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).
Tuzovic L; Tang S; Miller RS; Rohena L; Shahmirzadi L; Gonzalez K; Li X; LeDuc CA; Guo J; Wilson A; Mills A; Glassberg K; Rotterdam H; Sepulveda AR; Zeng W; Chung WK; Anyane-Yeboa K
Fetal Diagn Ther; 2015; 38(4):296-306. PubMed ID: 25998219
[TBL] [Abstract][Full Text] [Related]
4. Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.
Assia Batzir N; Kishor Bhagwat P; Larson A; Coban Akdemir Z; Bagłaj M; Bofferding L; Bosanko KB; Bouassida S; Callewaert B; Cannon A; Enchautegui Colon Y; Garnica AD; Harr MH; Heck S; Hurst ACE; Jhangiani SN; Isidor B; Littlejohn RO; Liu P; Magoulas P; Mar Fan H; Marom R; McLean S; Nezarati MM; Nugent KM; Petersen MB; Rocha ML; Roeder E; Smigiel R; Tully I; Weisfeld-Adams J; Wells KO; ; Posey JE; Lupski JR; Beaudet AL; Wangler MF
Hum Mutat; 2020 Mar; 41(3):641-654. PubMed ID: 31769566
[TBL] [Abstract][Full Text] [Related]
5. Familial visceral myopathy diagnosed by exome sequencing of a patient with chronic intestinal pseudo-obstruction.
Holla OL; Bock G; Busk OL; Isfoss BL
Endoscopy; 2014 Jun; 46(6):533-7. PubMed ID: 24777424
[TBL] [Abstract][Full Text] [Related]
6. Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.
Ravenscroft G; Pannell S; O'Grady G; Ong R; Ee HC; Faiz F; Marns L; Goel H; Kumarasinghe P; Sollis E; Sivadorai P; Wilson M; Magoffin A; Nightingale S; Freckmann ML; Kirk EP; Sachdev R; Lemberg DA; Delatycki MB; Kamm MA; Basnayake C; Lamont PJ; Amor DJ; Jones K; Schilperoort J; Davis MR; Laing NG
Neurogastroenterol Motil; 2018 Sep; 30(9):e13371. PubMed ID: 29781137
[TBL] [Abstract][Full Text] [Related]
7. Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.
Matera I; Rusmini M; Guo Y; Lerone M; Li J; Zhang J; Di Duca M; Nozza P; Mosconi M; Pini Prato A; Martucciello G; Barabino A; Morandi F; De Giorgio R; Stanghellini V; Ravazzolo R; Devoto M; Hakonarson H; Ceccherini I
Eur J Hum Genet; 2016 Aug; 24(8):1211-5. PubMed ID: 26813947
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome.
Wangler MF; Gonzaga-Jauregui C; Gambin T; Penney S; Moss T; Chopra A; Probst FJ; Xia F; Yang Y; Werlin S; Eglite I; Kornejeva L; Bacino CA; Baldridge D; Neul J; Lehman EL; Larson A; Beuten J; Muzny DM; Jhangiani S; ; Gibbs RA; Lupski JR; Beaudet A
PLoS Genet; 2014 Mar; 10(3):e1004258. PubMed ID: 24676022
[TBL] [Abstract][Full Text] [Related]
9. ACTG2 variants impair actin polymerization in sporadic Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.
Halim D; Hofstra RM; Signorile L; Verdijk RM; van der Werf CS; Sribudiani Y; Brouwer RW; van IJcken WF; Dahl N; Verheij JB; Baumann C; Kerner J; van Bever Y; Galjart N; Wijnen RM; Tibboel D; Burns AJ; Muller F; Brooks AS; Alves MM
Hum Mol Genet; 2016 Feb; 25(3):571-83. PubMed ID: 26647307
[TBL] [Abstract][Full Text] [Related]
10. De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis.
Thorson W; Diaz-Horta O; Foster J; Spiliopoulos M; Quintero R; Farooq A; Blanton S; Tekin M
Hum Genet; 2014 Jun; 133(6):737-42. PubMed ID: 24337657
[TBL] [Abstract][Full Text] [Related]
11. Novel ACTG2 variants disclose allelic heterogeneity and bi-allelic inheritance in pediatric chronic intestinal pseudo-obstruction.
Matera I; Bordo D; Di Duca M; Lerone M; Santamaria G; Pongiglione M; Lezo A; Diamanti A; Spagnuolo MI; Pini Prato A; Alberti D; Mattioli G; Gandullia P; Ceccherini I
Clin Genet; 2021 Mar; 99(3):430-436. PubMed ID: 33294969
[TBL] [Abstract][Full Text] [Related]
12. Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.
Moreno CA; Metze K; Lomazi EA; Bertola DR; Barbosa RH; Cosentino V; Sobreira N; Cavalcanti DP
Am J Med Genet A; 2016 Nov; 170(11):2965-2974. PubMed ID: 27481187
[TBL] [Abstract][Full Text] [Related]
13. Megacystis Microcolon Intestinal Hypoperistalsis Syndrome in Which a Different De Novo Actg2 Gene Mutation was Detected: A Case Report.
Korğalı EÜ; Yavuz A; Şimşek CEÇ; Güney C; Kurtulgan HK; Başer B; Atalar MH; Özer H; Eğilmez HR
Fetal Pediatr Pathol; 2018 Apr; 37(2):109-116. PubMed ID: 29608093
[TBL] [Abstract][Full Text] [Related]
14. Mutation in Actin γ-2 Responsible for Megacystis Microcolon Intestinal Hypoperistalsis Syndrome in 4 Chinese Patients.
Lu W; Xiao Y; Huang J; Tao Y; Yan W; Lu L; Cao Y; Cai W
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):624-626. PubMed ID: 27007401
[TBL] [Abstract][Full Text] [Related]
15. Expanding the genotypic spectrum of
James KN; Lau M; Shayan K; Lenberg J; Mardach R; Ignacio R; Halbach J; Choi L; Kumar S; Ellsworth KA
Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 33883208
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Pathology in Patients With Pathogenic
Kapur RP; Goldstein AM; Loeff DS; Myers CT; Paschal CR
Pediatr Dev Pathol; 2022; 25(6):581-597. PubMed ID: 35695198
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Chronic Intestinal Pseudo-obstruction and Megacystis by Sequencing the ACTG2 Gene.
Milunsky A; Baldwin C; Zhang X; Primack D; Curnow A; Milunsky J
J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):384-387. PubMed ID: 28422808
[TBL] [Abstract][Full Text] [Related]
18. ACTG2-Associated Visceral Myopathy With Chronic Intestinal Pseudoobstruction, Intestinal Malrotation, Hypertrophic Pyloric Stenosis, Choledochal Cyst, and a Novel Missense Mutation.
Collins RRJ; Barth B; Megison S; Pfeifer CM; Rice LM; Harris S; Timmons CF; Rakheja D
Int J Surg Pathol; 2019 Feb; 27(1):77-83. PubMed ID: 30019982
[TBL] [Abstract][Full Text] [Related]
19. Fetal megacystis-microcolon: Genetic mutational spectrum and identification of PDCL3 as a novel candidate gene.
Billon C; Molin A; Poirsier C; Clemenson A; Dauge C; Grelet M; Sigaudy S; Patrier S; Goldenberg A; Layet V; Tantau J; Fleury C; Liard A; Diguet A; Fritih R; Verspyck E; Rendu J; Boutaud L; Tessier A; Thomas S; Razavi F; Achaiaa A; Elkhartoufi N; Hakkakian L; Magnin E; Bôle-Feysot C; Masson C; Ville Y; Roth P; Prieur F; Bessieres B; Bonniere M; Attie-Bitach T
Clin Genet; 2020 Sep; 98(3):261-273. PubMed ID: 32621347
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
